A telehealth platform that pays by the signed order is asking a clinician to carry exposure the platform itself will never hold. DOJ and the HHS Office of Inspector General have spent the past decade building an enforcement record against practitioners who signed durable medical equipment (DME) and laboratory orders generated through a telehealth platform without a bona fide practitioner-patient relationship. The clinician whose name and National Provider Identifier appear on the order carries the liability for it, not the platform, the marketer, or the supplier that paid for the referral. Order volume, not clinical judgment, is what draws the government's attention first.
The Bona Fide Practitioner-Patient Relationship Standard
The federal standard for a valid telehealth order is not the call itself, it is what the call establishes. HHS-OIG's July 20, 2022 Special Fraud Alert on telemedicine arrangements lists seven suspect characteristics regulators watch for, and two recur in nearly every case DOJ has charged since: the practitioner lacks sufficient contact with or information from the patient to meaningfully assess medical necessity, and the telemedicine company pays the practitioner based on the volume of orders signed rather than the time or complexity of the encounter. A short intake call that never reaches the patient's actual condition does not create the relationship a DME or lab order requires. State medical board telehealth rules generally track the same requirement: a documented history, an exam or its telehealth equivalent, and a clinical basis specific to that patient before an order issues.
What DOJ Enforcement Has Targeted
DOJ's telehealth enforcement record already answers what happens to the signing practitioner. In the Power Mobility Doctor Rx (DMERx) prosecution, a federal jury convicted the platform's owner on June 3, 2025 for a scheme in which telemedicine companies paid doctors to sign orders for orthotic braces and other DME based on a brief phone call, or no patient contact at all. The orders falsely represented that a doctor had actually examined the beneficiary. DME suppliers and pharmacies that billed on those orders submitted more than $1 billion in claims, and Medicare and other insurers paid out more than $360 million before the scheme unraveled. The prescribing doctors, not only the platform executives, faced conspiracy to commit health care fraud and Anti-Kickback Statute charges tied to the orders bearing their own signatures.
Chart Review Adequacy and the Order Pipeline
A platform's intake questionnaire is not a chart review. Medical necessity for a DME or lab order has to trace to a documented history, a stated clinical finding, and a treatment rationale specific to the patient on that date, the same standard a UPIC applies when it pulls a sample of a practitioner's signed orders for audit. Orders that share identical diagnosis codes, identical equipment, or identical language across hundreds of patients are the pattern auditors flag first, and a pattern of unsupported orders can become an extrapolated recoupment demand reaching every claim the practitioner signed, not only the ones actually reviewed. Where the volume and the compensation arrangement are severe enough, the exposure moves past a recoupment and into a False Claims Act referral or a criminal charge, because every claim submitted on an unsupported order is a false claim.
Platform Contracts Rarely Protect the Signing Clinician
Most platform agreements assign compliance responsibility to the clinician while the platform keeps control over intake scripts and patient volume, the terms covered in Telehealth Platform Agreements: Terms That Create Liability for Clinicians. Signing orders for patients recruited across state lines also carries the licensure exposure in Practicing Across State Lines: Telehealth Licensure Enforcement, separate from the order itself. Telehealth Fraud Enforcement: What DOJ Actions Target traces the broader pattern DOJ has used against platforms, marketers, and signing practitioners alike.
The clinician whose name and NPI appear on a telehealth-generated order carries the liability for that order, whatever the platform's contract says about who is responsible.
Why Early Legal Counsel Is Critical
It is critical that telehealth clinicians promptly retain experienced healthcare defense counsel upon receiving a subpoena, an audit notice, a UPIC document request, or any other government inquiry tied to signed orders. Early legal intervention can protect the clinician's rights, shape the record before a sample of flagged orders hardens into an extrapolated demand, avoid inadvertent admissions during the platform's own internal review, and allow counsel to communicate with investigators on the clinician's behalf. Delaying representation narrows the options that remain once the government has already built its enforcement theory.
How Health Law Alliance Can Help
Health Law Alliance has handled 5,000+ matters across healthcare regulatory and audit defense over 25+ years, including telehealth order and DME investigations. If a platform contract, a DOJ subpoena, or a UPIC audit has put your signed orders under review, contact Health Law Alliance's telehealth defense attorneys for a free, confidential consultation before you respond.
